Skip to main content

RASD2 Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77313PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-77313PEP

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

A blocking peptide containing 16 amino acids near the amino terminus of human TEM2.

Source: Synthetic

(Accession #: Q96D21)

Purity

N/A

Application Notes

This peptide is useful as a blocking peptide for NBP1-77313.

For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-77313PEP
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
Preservative 0.02% Sodium Azide
Concentration 0.2 mg/ml
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: RASD2

RASD2 (RASD Family, Member 2) is involved in GTPase activity. While the exact function of RASD2 has yet to be determined, it is thought to have a role in signal transduction. RASD2 is known to have interactions with ACVR1, SMAD2, SMAD3, SMURF1 and PIK3CA. RASD2 has been studied in relation to Huntington's disease and pancreatitis.

Alternate Names

GTP-binding protein Rhes, MGC:4834, RASD family, member 2, Rhes, TEM2Ras homolog enriched in striatum, Tumor endothelial marker 2

Gene Symbol

RASD2

Additional RASD2 Products

Product Documents for RASD2 Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for RASD2 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...